BiotechTubeBiotechTube
Home/MBX Biosciences/Richard DiMarchi, PhD
RD

Richard DiMarchi, PhD

Scientific Co-Founder

MBX Biosciences

Therapeutic Areas

Endocrine DisordersMetabolic Disorders

MBX Biosciences Pipeline

DrugIndicationPhase
Canvuparatide (MBX 2109)Chronic Hypoparathyroidism (HP)Phase 2
Undisclosed PEP CandidatesVarious Endocrine and Metabolic DisordersDiscovery

Leadership Team at MBX Biosciences

KH
Kent Hawryluk
President and Chief Executive Officer
View full MBX Biosciences profile